Cargando…
Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment
Pancreatic cancer is one of the most lethal cancers among all malignances, with a median overall survival of <1 year and a 5-year survival of ~5%. The dismal survival rate and prognosis are likely due to lack of early diagnosis, fulminant disease course, high metastasis rate, and disappointing tr...
Autores principales: | Polireddy, Kishore, Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964134/ https://www.ncbi.nlm.nih.gov/pubmed/27471566 http://dx.doi.org/10.7150/jca.14922 |
Ejemplares similares
-
Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer
por: Wang, Rui, et al.
Publicado: (2021) -
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
por: Moon, Sun Joon, et al.
Publicado: (2021) -
Recent Treatment Advances and Novel Therapies in Pancreas Cancer: A Review
por: Valsecchi, Matias E., et al.
Publicado: (2013) -
Methotrexate Disposition, Anti-Folate Activity, and Metabolomic Profiling to Identify Molecular Markers of Disease Activity and Drug Response in the Collagen-Induced Arthritis Mouse Model
por: Salamoun, Yezan M., et al.
Publicado: (2021) -
Imaging of the pancreas: Recent advances
por: Chaudhary, Vikas, et al.
Publicado: (2011)